Search for: "Eli Lilly & Co."
Results 161 - 180
of 1,011
Sort by Relevance
|
Sort by Date
12 Jul 2017, 10:14 am
It will suffice to recall that the case stemmed from a complaint filed by Actavis against Eli Lilly in England seeking a declaration of non-infringement affecting not only England but also France, Italy and Spain. [read post]
12 Jul 2017, 2:30 am
This appeal considered whether a new pemetrexed based cancer treatment produced by Actavis UK Ltd & others infringes Eli Lilly & Co’s patent and its foreign designations either indirectly under the Patents Act 1977, s 60(2) (matter for appeal) or directly under a proper interpretation of the Europe Patent Convention 2000, art 69 (matter for cross-appeal). [read post]
10 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
3 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
2 Jul 2017, 12:52 am
(Eli Lilly v Novopharm (2010 FCA 197)This exercise requires:Reviewing the entire specification (claims and entire disclosure)Identifying the promises made in the entire specification Determining whether the patent fulfils those promises by demonstration or sound prediction.This exercise is a question of law viewed through the skilled person at the time of filing (with the assistance of expert evidence) and has been applied in several cases (BMS v Apotex (2005 FC 1348),… [read post]
1 Jul 2017, 9:39 am
(Eli Lilly v Novopharm (2010 FCA 197)This exercise requires:Reviewing the entire specification (claims and entire disclosure)Identifying the promises made in the entire specification Determining whether the patent fulfils those promises by demonstration or sound prediction.This exercise is a question of law viewed through the skilled person at the time of filing (with the assistance of expert evidence) and has been applied in several cases (BMS v Apotex (2005 FC 1348),… [read post]
27 Jun 2017, 5:45 pm
Eli Lilly & Co., 598 F.3d 1336, 1351(Fed. [read post]
26 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
19 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
12 Jun 2017, 6:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
5 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
23 May 2017, 2:35 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
22 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
21 May 2017, 10:00 pm
Elanco is an animal food producer and a division of Eli Lilly and Co. [read post]
15 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
10 May 2017, 10:41 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
9 May 2017, 4:42 am
Subsequently, the CJEU held in Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc [EU: C:2013:835] that Article 3(a) must be interpreted as meaning that it was not necessary for the active ingredient to be identified in the claim by means of a structural formula. [read post]
8 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
2 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
28 Apr 2017, 9:56 am
Eli Lilly & Co.). [read post]
